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Class I Alleles 
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From the Department ofHuman Immunology, DNAX Research Institute of Molecular and Cellular 
Biology, Palo Alto, California 94304 
Summary 
The killer cell inhibitory receptors (KilLs) are surface glycoproteins expressed by natural killer 
(NK) and T cells that specifically recognize defined groups of polymorphic human histocom- 
patibility leukocyte antigen (HLA) class I molecules. Interactions between KilLs on NK or T 
cells and major histocompatibility complex (MHC) class I molecules on potential target cells 
inhibit cell-mediated cytotoxicity, presumably by delivering a negative signal preventing lym- 
phocyte activation. In this study we examined whether KIRs also regulate cytokine production 
induced in response to T cell receptor-dependent T cell activation. CD4 + and CD8 + T cell 
clones were stimulated by bacterial superantigens in the presence or absence ofmonoclonal  an- 
tibodies (mAbs) against he Kilt. NKB1 or MHC class I molecules, and production of tumor 
necrosis factor o~ and interferon y was evaluated. When bacterial superantigen was presented by 
an autologous antigen-presenting cell (APC) to a KIlL + T cell clone, cytokine production was 
always enhanced in the presence o fant i -MHC class I mAb. Similarly, anti-KilL mAb also aug- 
mented cytokine production, provided that the APC expressed a HLA class I allele recognized 
by the Kill.. These results suggest hat recognition of autologous MHC class I molecules by 
K IR+ T cells provides a regulatory mechanism acting to modulate the potency of their re- 
sponses to antigenic hallenge. 
T he killer cell inhibitory receptors (KilLs) are a family of structurally related cell surface molecules that are 
expressed on subsets of  human NK and T cells (1-3). These 
receptors bind to polymorphic HLA class I glycoproteins 
(4), and this interaction prevents NK cells from killing po- 
tential target cells expressing certain HLA-B or HLA-C al- 
leles (5-7). lLecent studies suggest hat the Src homology 
region 2-domain phosphatase (SHP) tyrosine phosphatase may 
be responsible for the KilL-mediated inhibition of cytotox- 
icity (8). Although structurally unrelated, the Ly49 recep- 
tors expressed on mouse NK cells also recognize H-2 class I 
molecules and inhibit NK  cell-mediated cytotoxicity (9). 
While initially discovered on NK cells, KI1Ks are also 
present on subsets o fT  lymphocytes, including both CD4 + 
and CD8 + T cells (10-12). The expression of KIlL by T 
cells is intriguing because this suggests that T cell responses 
are regulated by two distinct, opposing receptors for MHC/  
peptide ligands. Whereas the TClL transmits positive sig- 
nals after engaging MHC/pept ide complexes, the KIlL may 
serve to dampen the extent of cellular activation, thereby 
regulating the signaling threshold required for effector cell 
function. Previously, we demonstrated that KI1Ks can in- 
hibit the lytic function of CTLs activated by bacterial su- 
perantigens (11). Here we examine the ability of the KIlL 
to regulate other T cell responses and demonstrate that dis- 
ruption of  KI1K recognition of  self-class I molecules leads 
to significant increases in T cell cytokine production in re- 
sponse to superantigen stimulation. 
Materials and Methods 
T Cell Clones and B Cell Lines. T cell clones were generated 
and maintained as described previously (13, 14). The HLA class 
I-negative B lymphoblastoid cell line (B-LCL) 721.221 was gen- 
erously provided by Dr. Robert DeMars (University of Wiscon- 
sin, Madison, WI) (15). 721.221 transfectants expressing HLA- 
B'5801 were generated as described previously (14). 
Antibodies and Flow Cytometry. mAbs were generously provided 
by Becton Dickinson Immunocytometry Systems (San Jose, CA). 
The anti-KItL-NKB1 mAb DX9 and anti-HLA-A,-B,-C mAb 
DX17 were produced and characterized in our laboratory (6, 11). 
The anti-KIN mAbs GL183 and EB6 mAbs were kindly pro- 
vided by Dr. Lorenzo Moretta (University of Genoa, Genoa, It- 
aly), and HP-3E4 by Dr. Miguel Lopez-Botet (University of 
Madrid, Madrid, Spain). Methods of immunofluorescence stain- 
ing and flow cytometry are described elsewhere (16). 
Cytokine Assays. T cell clones were cultured in 96-well flat- 
bottom microtiter plates (Becton Dickinson Labware, Lincoln 
Park, NJ) with or without Staphylococcus enterotoxin B (SEB, 
Toxin Technology Inc., Sarasota, FL). In some assays, 721.221 
cells or 721.221 cells transfected with HLA-B*5801 were pre- 
coated with SEB, washed to remove residual superantigen, and 
used as APCs at a stimulator to responder ratio of 1:1. After over- 
night incubation, triplicate 50-lxl samples of cell-free supernatant 
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Figure 1. KIP,, regulation of 
cytokine production by T cell 
clones. (A and B) A NKB1 ~, 
CD8 + T cell clone (TC867.9) 
(I0 c' cells/well) was cultured 
with 721.221 cells or 721.221 
cells transfected with HLA- 
B'5801 (10~l/well) in the pres- 
ence of control [gG1 (anti-Leu 
19, CD56), anti-NKB1 (DXg), 
or anti-HLA-A,B,C (DX17) (10 
i~g/ml). The 721.221 cells and 
transfectants were preincubated 
with or without 10 ng/ml of 
SEB (30 nfin at 37~ and 
washed, before coculture with T 
cells. (C and D) The T cell clone 
was incubated (without 721.221 
cells) in the presence or absence 
of 10 ng/nd of soluble SEB and 
anti-NKB1 or anti-HLA-A,-B. 
-C (10 p.g/ml), as indicated. Af- 
ter 20-h culture at 37~ cell- 
free supernatants were collected 
and assayed for TNF-c~ (A and 
(~ or IFN-~/ (B and D) by 
ELISA (meau of triplicate cul- 
tures, SI) <10%). 
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were collected from each well and IFN-~/and TNF-cl were mea- 
sured by ELISA, as previously described (17, 18). 
Intracellular Staining. Intracellular cytokines were detected by 
immunofluorescent staining, as described previously (19). PE- 
labeled anti-TNF-et and FlTC-labeled anti - IFN-y mAb were 
generously provided by Drs. Ken Davis and Skip Maino (Becton 
Dickinson Immunocytometry S stems)9 
Northern Blot Analysis. Northern blot analysis was performed 
as previously described (20), RNA (10 ~g/lane) was transferred 
to nylon membranes and hybridized with a 32p-labeled KIR-NKB 1 
eDNA probe (2). Radioactivity was detected using a Phosphor- 
Imager (Molecular Dynamics, Sunnyvale, CA)9 
Resu l ts  and  D iscuss ion  
Superantigens are viral and bacterial proteins that activate 
T lymphocytes by binding to MHC class II molecules on 
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sponding T cells (21). We previously demonstrated that 
KIP. + CTL kill superandgen-coated class I-negative B-LCL, 
but are inhibited when the potential target cells express a 
HLA class I allele reactive with the KIP`. Whereas KIP`s 
have been implicated in regulation of cytotoxicity in both 
NK and T cells, less is known about the role of these inhib- 
itory receptors in the regulation of other antigen-induced 
T cell functions, in particular, cytokine synthesis. To this 
end, we generated KIR +, TCR.-(x/[3 + T cell clones (both 
CD4 + and CD8 +) and selected them for further study 
based on their ability to produce cytokines in response to 
stimulation with SEB presented either by the HLA class 
I-deficient B-LCL 721.221 cell line or 721.221 transfec- 
tants stably expressing certain HLA class I alleles. The re- 
suits presented in Fig. 1 are from a representative CD8 + T 
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Figure 2. SEB-induced cytokine production by KIR + and KIP,.- T cell clones. For detection ofintracellu]ar cytokines, NKB1 + (AD130.2) (A) and 
NKB1- (T81) (B) T cell clones were either untreated or stimulated with 10 ng/nd of soluble SEB (4 h) in the presence or absence of the control IgG1, 
anti-NKB1, or anti-HLA-A,-B,-C (10 I.tg/ml). Cells were harvested after 4 h, fixed, and stained with fluorochrome-conjugated control Ig, PE anti- 
TNF-~, or FITC anti-IFN-7. Data are displayed as bivariate dot plots (x and y axes, 4-decade-log scales)9 In samples tained with FITC- and PE-conju- 
gated IgG control mAb, >98% of cells were in the lower fight quadrant (not shown). The total percentage of cells secreting TNF-~, IFN-% or both 
cytokines (sum of upper fight, upper left, and lower right quadrants) is indicated in each panel. For detection of secreted cytokines, T cell clones were 
cultured in the presence of increasing concentrations of SEB for 20 h at 37~ with 10 p.g/ml of control gGl mAb (~), anti-HLA-A,-B,-C (DX17) (O), 
anti-NKB1 (DX9) (A), or medium (C]). TNF-c~ and IFN-'y in the cell-free supernatants of the NKB1 + (A) or NKB1- (B) T cell clones were measured 
by ELISA (mean of triplicate cultures, SD <10%). 
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cell clone (Tc867.9) expressing the K IR  NKB1 which rec- 
ognizes HLA-Bw4 ligands (7). In the absence of SEB, no 
cytokines were produced in response to coculture with 
721.221 or a 721.221 transfectant expressing HLA-B*5801 
(a HLA-Bw4 allele). Higher levels of  TNF-ot and INF-y  
were secreted by the T cell clone when SEB was presented 
by the class I-negative APC, compared with the HLA- 
B'5801 + transfectant (Fig. 1, A and B). Suppression of  cy- 
tokine production by the HLA-B*5801 + APC apparently 
is regulated by the K IR  present on the T cell clone because 
anti-NKB1 mAb or anti-MHC class I mAb enhanced cy- 
tokine production to a level equal to or higher than when 
the SEB is presented by the HLA class I-negative APC. In 
parallel with experiments measuring cytokine secretion, 
this T cell clone was assayed for its ability to kill SEB- 
coated 721.221 or HLA-B*5801 + 721.221 cells, and con- 
sistent with prior findings, the NKB1 K IR  also inhibited 
superantigen-induced cytotoxicity against targets express- 
ing HLA-B*5801 (not shown). These results demonstrate 
that binding of  the K IR  to its class I ligand is not only ca- 
pable of modulating T cell-mediated cytotoxicity but also 
has inhibitory effects on T cell activation pathways leading 
to lymphokine production. These results are consistent 
with a prior study demonstrating effects ofanti-KIR mAb on 
cytokine production (10). 
Whereas studies with MHC-deficient EBV-transformed 
B-LCL cell lines transfected with a single class I allele are 
useful to analyze the specificity of  KIRs, they do not ad- 
dress the role of these inhibitory receptors in immune re- 
sponses initiated by normal, autologous APCs. Because ac- 
tivated human T cells express MHC class II, they are able 
to serve as APCs for superantigens. Therefore, this provides 
the opportunity to study KIRs regulation ofa T cell response 
in a completely autologous sy tem with SEB presented on 
autologous class II molecules and KIRs interacting with 
self-class I ligands. Preliminary studies demonstrated that 
HLA-DR + human T cell clones are capable of autopresen- 
ration of  SEB and that the response is blocked by anti- 
HLA-DR mAbs (data not shown). To examine the role of 
KIRs in the regulation of  cytokine production induced by 
autologous APCs, we selected a NKB1 + T cell clone from 
a HLA-Bw4 + individual so that the K IR  is capable of  in- 
teracting with a self-MHC class I ligand. These K IR + T 
cells were cultured with SEB in the presence or absence of 
anti-NKBl' or anti-HLA class I mAbs, and cytokines were 
measured (Fig. 1, C and D), When the T cell clone auto- 
presented SEB, lymphokine production (TNF-~x and INF-',/) 
was substantially increased if self-class I recognition by the 
KIR was disrupted by either anti-NKB1 or anti-class I mAb. 
These results demonstrate that interactions between KIRs 
and self-HLA class I molecules may regulate TCR- induced 
immune responses initiated by autologous APCs. It should 
be noted that we used the same NKB1 + T cell clone for 
the experiments shown in Fig. 1, A-D to directly compare 
SEB presentation by the 721.221 APC (Fig. 1, A and B) 
and the autologous T cell as APC (Fig. 1, C and D). Simi- 
lar results were obtained in both situations. 
Further experiments were performed to evaluate the ki- 
netics and the effects ofsuperantigen concentration on K IR 
regulation of  cytokine production. As shown in Fig. 2 A, a 
NKB 1 + CD4 + T cell clone (AD 130.2) was stimulated with 
SEB in the presence or absence ofanti-NKB1 or anti-HLA 
class I mAb. To examine early time points in the SEB- 
induced response, cytokines were detected by using immu- 
nofluorescence staining of  intracytoplasmic lymphokines. 
Substantially more TNF-o~ and INF-y  were present in the 
cytoplasm of K IR  + T cells stimulated in the presence of 
anti-NKB1 or anti-HLA class I mAb even within 4 h after 
SEB activation, After overnight culture, the ability of  KIRs 
to suppress cytokine secretion by SEB-activated T cells was 
evident at all concentrations of  superantigen tested, al- 
though at higher antigen doses the inhibition was not abso- 
lute, implying a quantitative regulation of  activation. In 
general, K IR  regulation of TNF-ix production was more 
profound than control of  IFN-y secretion. IL-2 was not 
detected in these cultures and superantigen stimulation did 
not induce substantial proliferation under the conditions 
studied. 
Whereas KIRs are present on a subset o fT  cells, many T 
cell clones lack expression of these molecules. For compar- 
ison with the K IR  + T cell clones, we selected T cell clones 
that were unreactive with all existing anti-KIR rnAbs (in- 
cluding EB6, GL183, HP-3E4, and Dxg)  and did not pos- 
sess K IR  transcripts as determined by Northern blot analy- 
sis (Fig. 3). These K IR -  T cells were evaluated for SEB 
responsiveness in the presence or absence of anti-HLA class 
I mAb. A representative K IR  CD4 + T cell clone (T81) is 
shown in Fig. 2 B. In this case, anti-HLA class I mAb had 
no effect on cytokine production induced by SEB, consis- 
tent with the lack of  inhibitory receptor for self-HLA class I. 
Whereas the NKB1 KIRs recognize HLA-Bw4 ligands, 
other members of the K IR  family react with HLA-C or 
HLA-A molecules (5, 22, 23). K IR  reactive with HLA-C 
may also regulate SEB-induced cytokine production. For 
example, the CD8 + T cell clone TC867.4 expresses a 
GL183 K IR  that presumably can interact with this individ- 
ual's HLA-Cw*0703 allele. Consistent with this possibility, 
anti-HLA class I mAb enhanced SEB-induced cytokine pro- 
duction by this T cell clone (Table 1). An individual NK 
cell clone can simultaneously express two or more KIRs on 
the cell surface (22, 24). Moreover, often KIRs are present 
on NK cells of individuals who apparently lack self-class I
alleles able to bind the receptor (25). Similarly, we have 
observed T cell clones expressing more than one K IR and 
Figure 3. Northern blot anal- 
ysis of KIR transcripts m T cell 
clones. Total RNA was ex- 
tracted from a KIR + NK cell 
line (lanes 1 and 4), from the 
KIR- T81 T cell clone (lane 2), 
and from the AD130.2 NKB1 + 
T cell clone (lane 3). The 
Northern blot was hybridized 
with 32p-labeled NKB1 probe. 
Equivalent amounts of RNA were loaded into each lane as determined by 
visual inspection of ethidium bromide~tained gels (not shown). 
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Table 1. Regulation ofTNF-oe and IFN-T Production by KIR Recognition ofSelf-class I Alleles 
IFN-y TNF-e~ 
KIR 
Clone Phenotype HLA type expression Medium ecNKB1 aHLA-I Medium cxNKB1 cxHLA-I 
pg/ml 
TC867.9 CD8 + A*0101, A'2902, NKB1 223 456 427 385 1,405 1,338 
TCR-~/~ B*0801 (Bw6), 
B'1302 (Bw4) 
Cw*0603, Cw*0703 
AD130.2 CD4 + A3, A30, NKB1 2,566* 8,315" 7,202* 944 6,548 5,880 
TCR-cx/~3 B49 (Bw4), B62 (Bw6), 
CW3, CW3 
TC867.4 CD8 + A*0101, A'2902, GL183 113 168 342 137 174 1,332 
TCR-ot/[3 B*0801 (Bw6), 
B'1302 (Bw4) 
Cw*0603, Cw*0703 
AD169.5 CD8 + A2, A3 NKB1, 589 474 1,287 153 102 687 
TCR-cx/~ B35 (Bw6), B50 (Bw6) GL183 
Cw4, Cw6 
T81 CD4 + A1, A29 None 978 946 778 2,634 2,490 1,927 
TCR-c~/[3 B8 (Bw6), B13 (Bw4) 
Cw6, Cw7 
T celt clones were analyzed by flow cytometry for their KIR expression. IFN-3~ and TNF-a were analyzed by ELISA after stimulation for 20 h with 
10 ng/rrd of SEB in the presence or absence ofanti-NKBl (DX9, 10 I~g/ml) or anti-MHC class-I (DXIT, 10 I~g/ml) mAbs. IgG1 control mAb had 
no effect on cytokine production (not shown). 
*SEB concentration = 5 ng/ml. 
receptors apparently unable to interact with self-class I
ligands. T cell clone AD169.5 represents a cell expressing 
two KIRs, NKB1 and GL183; however, this individual 
does not express a HLA-B or HLA-C  allele known to in- 
teract with NKB1 or GL183 (Table 1). Nonetheless, in 
functional assays, anti -HLA class I mAb augmented cyto- 
kine production, suggesting that yet another K IR  or inhib- 
itory receptor for a self-class I allele may be expressed by 
this clone. Results from these studies indicate that the dis- 
tribution and function of  KIRs on T cells are quite similar 
to NK cells and reveal the complexity of  analyzing T cell 
clones able to simultaneously express multiple KIRs, only 
some of  which may interact with self-class I ligands. 
In summary, our findings suggest hat KIRs affect not 
only NK cel l-mediated cytotoxicity, but also cytokine pro- 
duction by CD4 + and CD8 + T cells, implying a more gen- 
eral regulatory role in the immune system. The exact 
mechanisms governing K IR  expression on NK and T ceils 
are unclear at present and an understanding of  how the 
K IR  repertoire of  an individual is shaped by self-HLA is 
limited. We have observed that KIRs are preferentially ex- 
pressed on peripheral T cells with a "memory" phenotype 
and are rare in thymus and cord blood, suggesting that 
these inhibitory receptors may be expressed late during dif- 
ferentiation and serve to regulate responses against antigens, 
although this remains to be proven. It is tempting to specu- 
late that in the T cell lineage, KIP. may provide a novel 
mechanism to increase the threshold of  activation for effec- 
tor T cells, thereby prohibiting stimulation due to encoun- 
ters with low affinity, sel f -pept ide/MHC complexes. That 
these receptors, upon binding to their class I ligands, are 
able diminish the potency of  T cell responses, suggests a
mechanism for limiting T cell activation possibly operative 
in the maintenance of  tolerance or prevention of  autoim- 
munity. 
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